首页> 外文OA文献 >Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

【2h】

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

机译：无进展生存期高达8个月的晚期肝内胆管癌患者用阿凡扣治疗：案例报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fu-chao Ma; Qian Yu; Zhi-ming Zeng; Rong-quan He; Chao-hua Mo; Jin-cai Zhong; Jie Ma; Zhen-Bo Feng; Gang Chen; Xiao-Hua Hu;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report [J] . Fu-Chao Ma, Qian Yu, Zhi-Ming Zeng, OncoTargets and therapy . 2017,第6期

机译：阿帕替尼治疗的晚期肝内胆管癌患者长达8个月的无进展生存：一例报告
2. Apatinib for treating advanced intrahepatic cholangiocarcinoma after failed chemotherapy: A case report and literature review [J] . Li-Ye Wang Medicine. . 2018,第49期

机译：阿帕替尼治疗化疗失败后晚期肝内胆管癌的病例报告及文献复习
3. Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with Abemaciclib [J] . Sarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, The oncologist . 2021,第7期

机译：患者报告的结果预测患有ABEMACIBIB治疗的晚期乳腺癌患者的无进展生存
4. Plasma Adiponectin Lowering after left Ventricular Assist Device Implantation is Associated with 1-Month Survival in Patients with Advanced Heart Failure [C] . DAmico A., Caruso S., Cabiati M., International Congress on Coronary Artery Disease. . 2013

机译：降低左心室辅助装置植入后降低血浆脂联素与晚期心力衰竭患者的1个月存活相关
5. Association of patient-reported outcomes with progression-free survival in malignant pleural mesothelioma. [D] . Hackshaw, Michelle Denise. 2010

机译：患者报告的结局与恶性胸膜间皮瘤无进展生存的相关性。
6. Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report [O] . Fu-Chao Ma, Qian Yu, Zhi-Ming Zeng, 2017

机译：阿帕替尼治疗的晚期肝内胆管癌患者长达8个月的无进展生存：一例报告
7. P-103 Prognostic factors for survival in patients with advanced intrahepatic cholangiocarcinoma treated with gemcitabine plus cisplatin as first line treatment [O] . U. Ishimoto, M. Sasaki, S. Kondo, 2016

机译：用吉西他滨加顺铂治疗先进肝内胆管癌患者存活的P-103预后因素作为第一线治疗

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

著录项

引文网络

相似文献

相关主题

期刊订阅